SU-DHL-8 Cells
USUSD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
一般資訊
| 說明 | SU-DHL-8 is a human diffuse large B-cell lymphoma (DLBCL) cell line derived from an adult patient. It represents the activated B-cell-like (ABC) subtype of DLBCL, which is characterized by constitutive activation of the NF-κB signaling pathway and typically exhibits poorer prognosis compared to the germinal center B-cell-like (GCB) subtype. Morphologically, the SU-DHL-8 cells grow as large, loosely adherent aggregates in suspension, consistent with B-cell lymphoma phenotypes. Molecular characterization reveals that SU-DHL-8 harbors mutations commonly associated with ABC-DLBCL, including alterations affecting the BCR and NF-κB signaling pathways. Genomic profiling through next-generation sequencing and expression analysis has identified elevated activity in pathways such as JAK/STAT and BCL2-associated anti-apoptotic signaling. The cell line is also part of several large-scale pharmacogenomic studies and cancer model repositories, where it has been used to explore drug sensitivities, particularly to kinase inhibitors and proteasome-targeting agents. These features make SU-DHL-8 a representative and valuable model for investigating the molecular pathogenesis and therapeutic vulnerabilities of ABC-type DLBCL. |
|---|---|
| 生物體 | Human |
| 組織 | Pleural effusion |
| 疾病 | Diffuse large B-cell lymphoma germinal center B-cell type |
| 同義詞 | SUDHL8, SUDHL-8, SuDHL 8, Stanford University-Diffuse Histiocytic Lymphoma-8, DHL-8, DHL8 |
特徵
| 年齡 | 59 years |
|---|---|
| 性別 | Male |
| 族裔 | Caucasian |
| 形態學 | Lymphoblast-like |
| 細胞類型 | B lymphocyte |
| 生長特性 | Suspension, single cells and small clusters |
監管數據
| 引用 | SU-DHL-8 (Cytion catalog number 305877) |
|---|---|
| 生物安全等級 | 1 |
| NCBI_TaxID | 9606 |
| Cellosaurus 編號 | CVCL_2207 |
生物分子資料
| 抗原表達 | Ig+; IgM-, IgG-, IgA-, IgD-, Lambda-, Kappa- |
|---|---|
| 突變譜 | Mutation: KMT2D, Simple, p.Pro648Thrfs*2 (c.1940dupC) (c.1940_1941insC), Heterozygous (Cosmic-CLP=1331038), TP53, Simple, p.Tyr234Asn (c.700T>A), Heterozygous (Cosmic-CLP=1331038), TP53, Simple, p.Arg249Gly (c.745A>G), Heterozygous (Cosmic-CLP=1331038) |
處理方式
| 培養基 | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| 營養補充品 | Supplement the medium with 10% FBS |
| 解離試劑 | none |
| 倍增時間 | ~48-72 hours |
| 播種密度 | 0.3-0.5 x 106 cells/ml |
| 流體更新 | 2 to 3 times per week |
| 冷凍培養基 | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| 細胞解凍與培養 |
|
| 培養環境 | 37°C, 5% CO2, humidified atmosphere. |
| 運送條款 | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| 儲存條件 | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
品質控制與分子分析
| 不孕症 | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
分析證明書 (CoA)
| 批次編號 | 證書類型 | 日期 | 型號 |
|---|---|---|---|
| 305877-301025 | 分析證明書 | 05. Dec. 2025 | 305877 |
-
Related products
Related products